mHealth Apps Market size was valued at USD 44,008.6 Million in 2022, expanding at a CAGR of 12.3% from 2023 to 2030.
Medical personnel can benefit from mHealth applications, which have a variety of uses including patient-centered care, medication delivery, and usage as a teaching aid. It makes it possible to deliver healthcare and medical services via mobile applications, personal digital assistants, and wearable health monitoring devices with small, network-capable wearables. Through smartphone and fitness trackers, mHealth applications gather and analyze consumer health data.
mHealth Apps Market- Market Dynamics
The growing demand for fitness apps drives market growth
A poor diet, excessive alcohol use, a sedentary lifestyle, and little to no exercise have all been related to changes in lifestyle during the previous ten years. Global obesity rates are on the rise as a result of everything. Increased risk of cardiovascular, pulmonary, and other chronic illnesses, including cancer and diabetes, follow. During the COVID-19 pandemic, there was a rise in awareness of the deteriorating health and its long-term effects on quality of life. The epidemic inspired individuals to take better care of their health. Losing weight was the most frequent goal that prompted an increase in persons living active lifestyles. Numerous fitness applications that count calories, steps, heart rate, oxygen consumption, and other metrics saw a sharp increase in downloads. Customized diet and exercise programs with paid memberships also increased. People are adopting an active lifestyle and utilizing these applications as a part of it as the trend has persisted. Therefore, the worldwide mHealth market will expand as a result of the rising demand for fitness applications.
mHealth Apps Market- Key Insights
As per the analysis shared by our research analyst, the global mHealth app market is estimated to grow annually at a CAGR of around 12.3% over the forecast period (2023-2030).
The Blood Pressure Monitor industry is projected to grow at a significant rate owing to the rising awareness among the population.
Based on the product type, medical apps are expected to dominate the market during the forecast period.
Based on region, North America is expected to dominate the market during the forecast period.
mHealth Apps Market- Segmentation Analysis:
The Global mHealth Apps Market is segmented based on product type, platform, and Region.
Based on the product type, the global market is segmented into medical apps and fitness apps. The medical apps are expected to dominate the market during the forecast period. to improve communication and healthcare results, there is an increasing awareness among patients and healthcare providers to use medical apps. One of the key elements anticipated to propel the industry is the continued usage of paid medical applications by both patients and doctors. Additionally, a growing inclination for medical applications to control the symptoms of chronic diseases is fueling segment expansion.
mHealth Apps Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The market for mHealth apps is expanding in this region due to several factors, including rising geriatric population, rising prevalence of chronic diseases, improvements in coverage networks, and rising consumer awareness of the benefits of using mobile health applications. The adoption of such apps in this region is also being influenced by the increased marketing of medical health applications by healthcare practitioners in the U.S.
mHealth Apps Market- Competitive Landscape:
To remain competitive in the market the key players adopted various strategies including product launches, acquisitions, partnerships, agreements and others. The key players are Abbott Laboratories, AstraZeneca PLC, Teladoc Health, Inc., Merck and Co., Inc., Johnson and Johnson, Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd., Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Samsung Electronics Co. Ltd, Orange, Airstrip Technologies, Inc., Google (Alphabet), Inc., Qualcomm Technologies, Inc., Apple, Inc., AT&T and Allscripts among others.
Recent Developments:
In June 2022, major health-tech company Orange Health declared that as part of its ambitious regional growth plan, its services have started to be delivered in New Delhi. With this innovation, consumers may now access a variety of diagnostic services in the comfort of their homes throughout the NCR area, including Gurgaon, Noida, Delhi, and Ghaziabad, with reports being ready in only 60 minutes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MHEALTH APPS MARKET KEY PLAYERS
Abbott Laboratories
AstraZeneca PLC
Teladoc Health, Inc.
Merck and Co., Inc.
Johnson and Johnson
Bristol-Myers Squibb Company
Novartis AG
F. Hoffmann-La Roche Ltd.
Sanofi
Pfizer, Inc.
GlaxoSmithKline plc
Samsung Electronics Co. Ltd
Orange
Airstrip Technologies, Inc.
Google (Alphabet), Inc.
Qualcomm Technologies, Inc.
Apple, Inc.
AT&T
Allscripts
GLOBAL MHEALTH APPS MARKET, BY PRODUCT TYPE
Medical Apps
Fitness Apps
GLOBAL MHEALTH APPS MARKET, BY PLATFORM
Android
iOS
Others
GLOBAL MHEALTH APPS MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. mHealth Apps Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. mHealth Apps Market Snippet by Product Type